Table of Contents

Zota Health Care Ltd

Updated on November 15, 2024

Stock/Share Code - ZOTA

Zota Health Care is engaged in the Manufacturing & Trading in Pharmaceutical Products. The company caters to both domestic and international markets.

Below is the details of ZOTA Zota Health Care Ltd

Market Cap	₹364.24 Cr.
Current Price	₹302.4 as on 23 Mar 23
52 Week High / Low Price	₹206.4 / ₹121.1
Face Value	₹10
Stock P/E	134.41
Book Value	₹28.03
Dividend Yield	0.64 %
ROCE	5.73 %
ROE	4.01 %
Sales Growth (3yrs)	10.50 %
Sector	Pharmaceuticals
Industry	Pharmaceuticals - Indian - Bulk Drugs & Formln
Listed on	BSE
Company Website	Company Website

Pros: Company is virtually debt free. Company has been maintaining a healthy dividend payout of 64.32%

Cons: Stock is trading at 5.58 times its book value The company has delivered a poor growth of 11.31% over past five years. Company has a low return on equity of 8.35% for last 3 years.

Zota Health Care Ltd Price Chart

Zota Health Care Ltd Peer Comparison in Pharmaceuticals

S.No.	Name	CMP Rs.	P/E	Mar Cap Rs.Cr.	Div Yld %	NP Qtr Rs.Cr.	Qtr Profit Var %	Qtr Sales Var %	Sales Qtr Rs.Cr.	ROCE %
1.	Sun Pharma.Inds.	₹19.55	28.81	₹124,825.4 Cr.	0.77	-₹1,655.6 Cr.	24.82	-9.42	7585.25	10.53
2.	Dr Reddy's Labs		36.47	₹70,902.77 Cr.	0.59	₹594.6 Cr.	-12.11	14.73	4426.50	11.11
3.		34.95	₹57,535.92 Cr.	0.42	₹577.91 Cr.	20.85	8.95	4346.16	11.77
4.	Aurobindo Pharma		15.87	₹47,396.57 Cr.	0.37	₹780.58 Cr.	20.99	8.82	5924.78	18.73
5.	Biocon		70.21	₹45,138 Cr.	0.13	₹149.4 Cr.	-27.58	14.56	1671.30	13.11
6.	Torrent Pharma.		39.86	₹45,039.6 Cr.	0.64	₹321 Cr.	48.61	1.68	2056.00	15.01
7.	Cadila Health.		26.88	₹38,006.44 Cr.	0.94	₹454 Cr.	49.54	4.11	3639.90	11.83
8.	Zota Health Care		134.41	₹364.24 Cr.	0.64	₹0.51 Cr.	-8.93	-19.05	17.55	5.73

Ready to Invest?
Talk to our investment specialist

Zota Health Care Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

	Jun 2016	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020
Sales -	17.61	24.22	21.76	20.60	21.68	25.29	25.06	23.08	17.55
YOY Sales Growth %						4.42%	15.17%	12.04%	-19.05%
Expenses -	15.22	20.86	21.49	18.96	20.83	23.87	24.33	21.55	16.40
Material Cost %	78%	66%	70%	65%	69%	71%	71%	67%	66%
Employee Cost %	8%	9%	10%	13%	11%	10%	10%	12%	12%
Operating Profit	2.39	3.36	0.27	1.64	0.85	1.42	0.73	1.53	1.15
OPM %	13.57%	13.87%	1.24%	7.96%	3.92%	5.61%	2.91%	6.63%	6.55%
Other Income	0.00	0.62	0.17	0.37	0.30	0.37	0.31	0.53	0.23
Interest	0.02	0.00	0.01	0.02	0.01	0.01	0.02	0.02	0.01
Depreciation	0.25	0.35	0.37	0.26	0.30	0.32	0.48	1.00	0.74
Profit before tax	2.12	3.63	0.06	1.73	0.84	1.46	0.54	1.04	0.63
Tax %	33.02%	31.96%	-383.33%	32.95%	32.14%	25.34%	29.63%	30.77%	19.05%
Net Profit	1.42	2.46	0.28	1.15	0.56	1.09	0.38	0.73	0.51
EPS in Rs	0.71	1.00	0.08	0.34	0.16	0.44	0.15	0.30	0.21
	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	TTM
Sales -	37.64	43.31	49.42	55.65	64.14	70.49	77.02	85.23	95.11	90.98
Sales Growth %		15.06%	14.11%	12.61%	15.26%	9.90%	9.26%	10.66%	11.59%
Expenses -	32.81	37.41	42.91	47.17	54.58	60.45	66.12	77.48	90.57	86.15
Material Cost %	70%	70%	69%	66%	66%	64%	66%	67%	70%
Manufacturing Cost %	3%	3%	3%	3%	3%	3%	3%	3%	0%
Employee Cost %	7%	7%	7%	8%	8%	9%	9%	10%	11%
Other Cost %	7%	6%	7%	7%	8%	10%	8%	11%	15%
Operating Profit	4.83	5.90	6.51	8.48	9.56	10.04	10.90	7.75	4.54	4.83
OPM %	12.83%	13.62%	13.17%	15.24%	14.90%	14.24%	14.15%	9.09%	4.77%	5.31%
Other Income	0.03	0.03	0.10	0.01	0.08	0.06	1.50	1.54	1.51	1.44
Interest	0.51	0.79	0.71	0.66	0.68	0.68	0.12	0.04	0.07	0.06
Depreciation	1.39	1.35	1.21	1.51	1.23	1.05	0.94	1.39	2.10	2.54
Profit before tax	2.96	3.79	4.69	6.32	7.73	8.37	11.34	7.86	3.88	3.67
Tax %	33.11%	32.45%	33.26%	32.59%	33.76%	33.69%	35.98%	29.39%	28.87%
Net Profit	1.98	2.55	3.13	4.26	5.11	5.54	7.27	5.55	2.76	2.71
EPS in Rs	1.30	1.40	1.75	1.97	2.39	2.76	2.95	2.25	1.12	1.10
Dividend Payout %	50.35%	46.94%	38.24%	33.71%	28.10%	51.84%	72.38%	31.60%	88.99%

Compounded Sales Growth

5 Years:: 11.31%
3 Years:: 10.50%
TTM:: 3.08%

Compounded Profit Growth

5 Years:: -8.31%
3 Years:: -20.73%
TTM:: -39.10%

Return on Equity

3 Years:: 18.43%
1 Year:: -11.63%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
Share Capital -	9.97	11.97	11.97	14.36	14.36	14.36	17.54	17.54	24.56
Equity Capital	9.97	11.97	11.97	14.36	14.36	14.36	17.54	17.54	24.56
Reserves	2.73	1.90	3.64	3.74	7.08	12.62	52.23	51.39	44.29
Borrowings	5.97	5.41	4.82	5.25	2.23	4.10	0.00	0.00	0.00
Other Liabilities -	9.81	10.11	12.74	15.02	20.39	22.72	22.02	20.69	19.64
Trade Payables	6.45	7.16	9.79	11.71	14.60	18.36	16.47	16.17	14.99
Advance from Customers	1.04	0.19	0.20	0.38	0.23	0.00	0.00	0.00
Other liability items	2.32	2.76	2.75	2.93	5.56	4.36	5.55	4.52	4.65
Total Liabilities	28.48	29.39	33.17	38.37	44.06	53.80	91.79	89.62	88.49
Fixed Assets -	9.81	9.13	9.07	8.23	7.23	6.72	9.56	9.78	29.44
Gross Block	9.81	9.13	9.07	8.23	14.42	14.98	18.76	20.36
Accumulated Depreciation	0.00	0.00	0.00	0.00	7.19	8.26	9.19	10.59
CWIP	0.05	0.05	0.00	0.00	1.13	2.50	0.04	1.55	0.00
Investments	0.06	0.07	0.08	0.08	0.09	0.00	26.15	15.62	0.00
Other Assets -	18.56	20.14	24.02	30.06	35.61	44.58	56.04	62.67	59.05
Inventories	10.17	10.98	12.53	17.62	16.33	23.91	24.28	32.51	25.34
Trade receivables	7.33	8.40	10.68	11.69	15.78	17.08	22.93	22.10	29.14
Cash Equivalents	0.12	0.13	0.14	0.16	0.76	0.14	2.46	1.69	0.73
Loans n Advances	0.82	0.52	0.56	0.47	2.63	3.35	6.07	6.07	3.48
Other asset items	0.12	0.11	0.11	0.12	0.11	0.10	0.30	0.30	0.36
Total Assets	28.48	29.39	33.17	38.37	44.06	53.80	91.79	89.62	88.49

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
Cash from Operating Activity -	4.93	2.76	3.00	4.28	4.56	3.35	-4.43	-3.24	5.54
Profit from operations	4.79	5.89	6.56	8.44	9.58	10.07	10.93	7.87	4.94
Receivables	-2.23	-1.07	-2.28	-1.01	-4.09	-1.31	0.00	0.00	-7.04
Inventory	-4.69	-0.80	-1.55	-5.09	1.29	-7.58	-0.37	-8.23	7.17
Payables	2.98	0.72	2.62	1.92	2.89	3.75	-7.74	0.53	-1.18
Loans Advances	0.65	0.45	-0.08	0.07	-0.54	-0.48	-1.84	1.40	0.24
Operating borrowings	1.95	-0.66	-0.26	2.00	-3.02	0.00	-1.64	0.00	0.00
Other WC items	2.10	-0.53	-0.43	0.16	1.15	1.76	0.27	-2.48	2.51
Working capital changes	0.76	-1.90	-1.98	-1.96	-2.32	-3.85	-11.32	-8.78	1.69
Direct taxes	-0.62	-1.23	-1.57	-2.20	-2.69	-2.87	-4.04	-2.32	-1.10
Cash from Investing Activity -	-3.41	-0.67	-1.09	-0.70	-1.35	-1.81	-26.19	8.83	-3.53
Fixed assets purchased	-3.59	-0.68	-1.11	-0.72	-1.38	-1.92	-1.32	-3.12	-6.18
Fixed assets sold	0.15	0.00	0.01	0.00	0.03	0.02	0.00	0.00	0.00
Investments purchased	0.00	-0.01	-0.01	-0.01	-0.01	0.00	-26.35	0.00	0.00
Investments sold	0.00	0.00	0.00	0.00	0.00	0.00	0.00	10.54	1.59
Interest received	0.03	0.01	0.01	0.01	0.01	0.01	1.48	1.41	1.05
Other investing items	0.01	0.00	0.00	0.01	0.01	0.09	0.00	0.00	0.01
Cash from Financing Activity -	-1.71	-2.09	-1.89	-3.56	-2.62	-2.16	32.94	-6.35	-2.97
Proceeds from shares	3.32	1.99	0.00	2.39	0.00	0.00	3.18	0.00	0.00
Proceeds from borrowings	0.00	0.00	0.00	0.00	0.00	0.23	0.00	0.00	0.00
Repayment of borrowings	-0.26	-1.08	-0.59	-0.22	0.00	0.00	-2.46	0.00	0.00
Interest paid fin	-0.46	-0.76	-0.67	-0.63	-0.64	-0.66	-0.11	-0.02	-0.01
Dividends paid	-1.00	-1.20	-1.20	-1.44	-1.44	-1.44	-3.53	-5.26	-2.46
Other financing items	-3.31	-1.05	0.56	-3.67	-0.55	-0.29	35.85	-1.07	-0.51
Net Cash Flow	-0.19	0.00	0.02	0.02	0.59	-0.62	2.33	-0.77	-0.97

Ready to Invest?
Talk to our investment specialist

Ratios

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
ROCE %		24.14%	27.20%	31.89%	35.73%	33.02%	22.77%	11.39%	5.73%
Debtor Days	71.08	70.79	78.88	76.67	89.80	88.44	108.67	94.64	111.83
Inventory Turnover		2.89	2.93	2.46	2.50	2.26	2.14	2.03	2.29

Announcements & News

Recent Announcements

Copy of Newspaper Publication | Aug. 27, 2020
Updates | Aug. 26, 2020
Copy of Newspaper Publication | Aug. 26, 2020
Shareholders meeting | Aug. 25, 2020
Statement of deviation(s) or variation(s) under Reg. 32 | Aug. 25, 2020

Annual Reports

Financial Year 2019 | from nse

How to Invest in Mutual Funds SIP Online?

Open Free Investment Account for Lifetime at Fincash.com.
Complete your Registration and KYC Process
Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
Invest in Mutual Funds which invests in Zota Health Care Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.

Shepard Technologies Pvt. Ltd : 1808, Solus, Hiranandani Estate, Thane, Maharashtra - 400607

AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153

Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing. Past performance is not indicative of future returns. Please consider your specific investment requirements before choosing a fund, or designing a portfolio that suits your needs.

Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.